Skip to content
Search AI Powered

Latest Stories

Pharmacy bodies, students intensify their calls for clarity on assessment glitches

Pharmacy bodies and students have further intensified their calls urging the GPhC to resolve all registration assessment booking chaos immediately to ease mounting pressure on the exam candidates.

In separate statements, the PDA and the BPSA have demanded urgent action by the pharmacy regulator to retain the credibility of online registration assessment.


The exam candidates have experienced problems with their arrangements after they encountered issues including delayed communications, limited spaces to sit remotely, among others.

Last week, chaos around the communication and booking system from Pearson Vue has resulted in some candidates expected to travel miles to a test center and others being left without a place to sit for the assessment.

“In response to the current issues, the PDA believe the GPhC, and their supplier Pearson Vue, should either create more capacity and/or offer more remote sittings,” the association said.

Collette Bradford, PDA Director of Organising & Engagement, added: “The PDA calls for the GPhC to acknowledge the challenges that these candidates have faced, the contribution that many of them have made to the response to the pandemic and patient care, and the resilience that they have demonstrated in the face of uncertainty and unprecedented circumstances associated with their unique journey to registration.

“The PDA support our members and believe it is fair and reasonable that this March 2021 assessment, the first ever online attempt, should not count towards a candidate’s three attempts to pass the entire assessment in one sitting.”

BPSA seeks for clarification on time slots

Meanwhile, the British Pharmaceutical Students' Association (BPSA) has urged GPhC to clarify whether candidates who had booked their registration exam slot in the afternoon will still be able to sit the exam.

Some trainees have reported that starting time of their assessment ranges from 8am to 3pm.

“Urgent clarification needs to be provided regarding the varying assessment time slots, as well as assurance to candidates who have booked slots that should not have been available and those who are awaiting to book, that they will still be able to sit the registration assessment in March without any further delay,” the organisation said in a statement last week.

Commenting on the rising concerns over March 17, 18 assessment, the GPhC assured that all technical glitches are being resolved for the smooth conduction of the exams.

GPhC said in a tweet: “Candidates: we are making good progress in identifying solutions to the capacity issues identified. We will be in touch with candidates who have so far been unable to secure a place as soon as we possibly can.”

“We’re also working with @PearsonVUE  to book remote sittings for candidates with reasonable adjustments and who are overseas- we’ll send these candidates an update tomorrow.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less